![Alex Aimetti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Alex Aimetti worked at Invivo Therapeutics Holdings Corp.
from 2012 to 2018, serving as VP-Medical Education & Product Strategy from 2015 to 2018.
Employment at Immedica Pharma US, Inc. spanned from 2018 to 2025, including the role of Chief Scientific Officer from 2023 to 2025.
Employment at DiaMedica Therapeutics, Inc. occurred from 2025 to 2026 as Chief Development Officer.
Education includes undergraduate studies at Worcester Polytechnic Institute and a doctorate from the University of Colorado Boulder.
Ehemalige bekannte Positionen von Alex Aimetti
| Unternehmen | Position | Ende |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Corporate Officer/Principal | 01.02.2026 |
| MARINUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2025 |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Corporate Officer/Principal | 01.03.2018 |
Ausbildung von Alex Aimetti
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
53
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Worcester Polytechnic Institute
 Worcester Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Invivo Therapeutics Holdings Corp.
 Invivo Therapeutics Holdings Corp. BiotechnologyHealth Technology Develops technologies for the treatment of spinal cord injuries | Health Technology |
University of Colorado Boulder
 University of Colorado Boulder Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
